PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS

Clinical trial NCT07761533 · RECRUITING

Trial details

NCT number: NCT07761533
Sponsor: Chaser Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome)

Start date: 2025-09-08
Primary completion: 2027-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.